APA

Ohhara H., Ogawa T., Takeda M., Katoh H., Daiku Y. & Igarashi T. (19890614). Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs. : Arzneimittel-Forschung.

Chicago

Ohhara H, Ogawa T, Takeda M, Katoh H, Daiku Y and Igarashi T. 19890614. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs. : Arzneimittel-Forschung.

Harvard

Ohhara H., Ogawa T., Takeda M., Katoh H., Daiku Y. and Igarashi T. (19890614). Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs. : Arzneimittel-Forschung.

MLA

Ohhara H, Ogawa T, Takeda M, Katoh H, Daiku Y and Igarashi T. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs. : Arzneimittel-Forschung. 19890614.